Chemdex Inc – FDA 483, Feb 27, 2023
An FDA inspection of Chemdex Inc., an API manufacturer in Lenexa, KS, revealed significant deficiencies across three observations. The firm failed to establish adequate preventative maintenance schedules and cleaning procedures for equipment used in manufacturing Iron Hydrogenated Dextran Bulk Solution 10%. Additionally, the inspection found a lack of proper monitoring and control for microbial counts and endotoxins in water used in final manufacturing steps for a non-sterile API intended for a sterile drug product.
ID · d77bc039-84a8-43cc-924e-ff781bf5fc19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.